Targeted Medical Pharma, Inc.: 10-Q filed 2013-05-15
What Targeted Medical Pharma, Inc. reported in its quarterly report filed 2013-05-15 (fiscal Q1 2013): 31 published measures, 67 facts as tagged in accession 0001144204-13-029593.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2013-05-15
- Fiscal period
- fiscal Q1 2013
- Accession
- 0001144204-13-029593 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All Targeted Medical Pharma, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 12,224,838 | USD | |
| At 2012-12-31 | 11,775,360 | USD | |
| At 2012-03-31 | 9,555,986 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 14,205,973 | USD | |
| At 2012-12-31 | 13,777,396 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | -1,981,135 | USD | |
| At 2012-12-31 | -2,002,036 | USD | |
| At 2011-12-31 | 607,438 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 57,936 | USD | |
| At 2012-12-31 | 326,603 | USD | |
| At 2012-03-31 | 10,847 | USD | |
| At 2011-12-31 | 147,364 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | -270,277 | USD | 90 |
| 2012-01-01 to 2012-12-31 | -9,586,182 | USD | 366 |
| 2012-01-01 to 2012-03-31 | -975,917 | USD | 91 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | 24,728 | USD | 90 |
| 2012-01-01 to 2012-03-31 | -1,352,099 | USD | 91 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | 11,208 | USD | 90 |
| 2012-01-01 to 2012-03-31 | 27,866 | USD | 91 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | 2,811,131 | USD | 90 |
| 2012-01-01 to 2012-03-31 | 1,375,185 | USD | 91 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | -225,000 | USD | 90 |
| 2012-01-01 to 2012-03-31 | 1,270,000 | USD | 91 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | -68,395 | USD | 90 |
| 2012-01-01 to 2012-03-31 | -54,418 | USD | 91 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | -13,955,066 | USD | |
| At 2012-12-31 | -13,684,789 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 315,927 | USD | |
| At 2012-12-31 | 340,096 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | 284,638 | USD | 90 |
| 2012-01-01 to 2012-03-31 | 176,330 | USD | 91 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | -508,261 | USD | 90 |
| 2012-01-01 to 2012-03-31 | -1,571,168 | USD | 91 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 2,875,480 | USD | |
| At 2012-12-31 | 2,598,813 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 12,736,813 | USD | |
| At 2012-12-31 | 12,314,722 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 519,858 | USD | |
| At 2012-12-31 | 353,993 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | 2,420,718 | USD | 90 |
| 2012-01-01 to 2012-03-31 | 2,311,618 | USD | 91 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 694,478 | USD | |
| At 2012-12-31 | 478,499 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | 1,912,457 | USD | 90 |
| 2012-01-01 to 2012-03-31 | 740,450 | USD | 91 |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | 2,388,638 | USD | 90 |
| 2012-01-01 to 2012-03-31 | 2,284,354 | USD | 91 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | 32,080 | USD | 90 |
| 2012-01-01 to 2012-03-31 | 27,264 | USD | 91 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 23,008,782 | shares | |
| At 2012-12-31 | 23,008,782 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 11,950,919 | USD | |
| At 2012-12-31 | 11,659,744 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 2,310,628 | USD | |
| At 2012-12-31 | 2,318,619 | USD |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | 100,555 | USD | 90 |
| 2012-01-01 to 2012-03-31 | 111,236 | USD | 91 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | -1,539 | USD | 90 |
| 2012-01-01 to 2012-03-31 | -75,839 | USD | 91 |
Deferred income tax expense or benefit
The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | -239,523 | USD | 90 |
| 2012-01-01 to 2012-03-31 | -671,090 | USD | 91 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | 165,865 | USD | 90 |
| 2012-01-01 to 2012-03-31 | -278,208 | USD | 91 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | 215,979 | USD | 90 |
| 2012-01-01 to 2012-03-31 | 352,153 | USD | 91 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | 82,247 | USD | 90 |
| 2012-01-01 to 2012-03-31 | 119,211 | USD | 91 |
Inspect the source
- Entity
- Targeted Medical Pharma, Inc. / CIK 0001420030
- Captured
- SEC response SHA-256
ca03716eae22460fbd50b309d17f5dd90795ea400593e50d5768fd8934ffb155
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001420030.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))